Gallium: Clinical Trials

2 trials of Gallium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Recruiting 1
Phase 21Completed 1

Follow Gallium: new trials by email Literature Review of Gallium trials Research Report on Gallium

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
AAA617, piflufolastat (18F), gallium (68Ga) gozetotide (25μg) - Oligometastatic Prostate Cancer (OMPC)
Phase 3RecruitingNovartis Pharmaceuticals4502024-03-122026-10-21
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
68Ga-RM2, Magnetic Resonance Imaging, Positron Emission Tomography - Prostate Adenocarcinoma
Phase 2 / Phase 3CompletedAndrei Iagaru1222015-11-162023-04-10

Sponsors

Andrei Iagaru (1)  ·  Novartis Pharmaceuticals (1)

Countries

United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Colombia (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Israel (1)

Top investigators

Andrei Iagaru (1)

Results publications

PMID 31478089, PMID 34406051, PMID 37555901, PMID 38423030